...
首页> 外文期刊>Protein engineering design & selection: PEDS >Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season
【24h】

Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season

机译:流感演变和H3N2疫苗有效性,应用于2014/2015赛季

获取原文
获取原文并翻译 | 示例
           

摘要

Influenza A is a serious disease that causes significant morbidity and mortality, and vaccines against the seasonal influenza disease are of variable effectiveness. In this article, we discuss the use of the p(epitope) method to predict the dominant influenza strain and the expected vaccine effectiveness in the coming flu season. We illustrate how the effectiveness of the 2014/2015 A/Texas/50/2012 [clade 3C.1] vaccine against the A/California/02/2014 [clade 3C. 3a] strain that emerged in the population can be estimated via p(epitope). In addition, we show by a multidimensional scaling analysis of data collected through 2014, the emergence of a new A/New Mexico/11/2014-like cluster [clade 3C. 2a] that is immunologically distinct from the A/California/02/2014-like strains.
机译:甲型流感是一种严重的疾病,会导致很高的发病率和死亡率,而针对季节性流感的疫苗具有不同的功效。在本文中,我们讨论了使用p(表位)方法来预测流行性感冒菌株以及在即将来临的流感季节中预期的疫苗有效性。我们说明了2014/2015 A / Texas / 50/2012 [clad 3C.1]疫苗对A / California / 02/2014 [clade 3C]的有效性。 [3a]可以通过p(表位)估计种群中出现的菌株。此外,我们通过对2014年之前收集的数据进行多维比例分析,得出了一个新的类似A / New Mexico / 11/2014的集群[clad 3C]的出现。 [2a]在免疫学上不同于A / California / 02 / 2014-like菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号